FDA
approval
· 2018-11-19
FDA Tentative Approval: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)
Summary
FDA issued tentative approval for Teva Respiratory's supplemental NDA for QVAR REDIHALER (beclomethasone dipropionate HFA). The inhaled corticosteroid is intend…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL TA for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)